Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Lexaria Bioscience (LEXX)

December 2, 2024 6:48 AM EST Send to a Friend
H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $10.00 price target on Lexaria Bioscience (NASDAQ: LEXX).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login